The aim is durability, not a longer wait.
Long term, I want to reverse neurodegeneration and materially slow biological aging, in whichever order the evidence supports. That is an ambition. It may fail. It is not a plan with a date.
NOVEL BIOTECH — CONCEPT STAGEPUBLIC RESEARCH RECORD
Evolution is too slow.
I am building Novel Biotech to make the human body and mind materially less fragile, on a timescale that matters to people alive now. Today it is one founder, a set of open questions, and the evidence behind them. There is no product, therapy, or development program.
- CONCEPT STUDY
- RESEARCH ONLY
- NO HUMAN TESTING
- NOT AVAILABLE
- NO DEVELOPMENT PROGRAM EXISTS
What exists is a record, not a company.
There is no entity, staff, laboratory, funding, selected indication, or patient. What exists is a public record: a research direction, two concept studies, an evidence register with its limits stated, and dated reports that preserve earlier conclusions.
Claims need a source and a stated limit.
The evidence register separates fact, plan, hypothesis, and ambition. Each source is listed with what it supports and what it does not show. An ambition is never presented as a result.
I am looking for the people first.
There is no role, salary, or contract to offer yet. I am preparing a way to hear from people who want to do this work. You can read the question now; Join shows whether sending is available.
Read how to join